Issues concerning the estimation of the TD50.

Area of Science:

• Toxicology
• Carcinogenesis
• Statistical Modeling

Background:

• The TD50 (tumorigenic dose 50) is a standard metric for assessing a chemical's carcinogenic potency in animal models.
• Accurate estimation of TD50 is crucial for risk assessment and regulatory decision-making.
• Potential sources of error in TD50 calculation include intercurrent mortality and selective reporting of significant findings.

Purpose of the Study:

• To investigate and quantify errors in TD50 estimation.
• To evaluate the impact of intercurrent mortality and the consideration of only significant TD50 values on potency estimation.
• To explore methods for improving the accuracy of TD50 calculations.

Main Methods:

• Utilized computer simulations to model and analyze TD50 estimation under various conditions.
• Assessed the influence of treatment-related toxicity on TD50 estimates.
• Examined the sensitivity of TD50 estimates to changes in tumor lethality and tumor incidence rates.

Main Results:

• Treatment-related toxicity demonstrated a minimal impact on TD50 estimation, with errors rarely exceeding 5%.
• TD50 estimates were highly sensitive to variations in tumor lethality, leading to errors as high as 50%.
• A significant portion of the observed errors were statistically significant, indicating a need for methodological refinement.

Conclusions:

• Intercurrent mortality and the focus on significant TD50 values can introduce substantial errors in carcinogenic potency assessment.
• Estimating TD50 based on tumor incidence rates, when tumor lethality data is available, offers a more accurate approach.
• Refining TD50 estimation methods is essential for reliable chemical risk evaluation.